The graphene oxide exposure concentrations (mg/m) measured based on the weight of the polycarbon filter before and after sampling were 0.46 ± 0.06 and 3.76 ± 0.24 for the low- and high-concentration groups, respectively (Table 2).
The proportion of men with a previous exam for infertility was higher among all three of the below-reference semen parameter groups (48%, 36%, and 40% for sperm concentration, motility, and morphology groups, respectively) than among the comparison group (25%).
However, in ATI-positive samples, the median CRP concentration was similar in these two groups (respectively 11.9 vs. 11.6 mg/L), although significantly different after correcting for multiple observations per patient (p=0.019) (figure 4).
The two-sample t-test was performed to compare the age, education level, BMI, ZSDS scores, and plasma concentration of E2 between the SSD and HC groups, respectively.
The mean serum vancomycin concentration on day 1 was 21.5 (6.4) and 24.5 (5.2) mg/L, for both groups respectively.
Amniotic fluid concentrations averaged 8.7 and 21.0 ng/mL for the low- and high-dose groups, respectively.
The reductions in estradiol concentrations were more pronounced at the higher dose, being 52%and79%9% in BDE01 and BDE10 groups, respectively.
Results: Immediately after erythropoietin injection, plasma erythropoietin concentration was elevated approximately 25- and 250-fold in the low and high erythropoietin dose groups, respectively.
The CA19-9 concentratinn in HCS-treated groups (mean was 281.5U/ml and 262.8U/ml in HCS-L and HCS-H groups respectively) differed significantly from that of the Control (388.1U/ml).
Both the albumin and IgM concentrations in the serum of D1 D3 groups were significantly lower than those of D4 and D5 groups, respectively (P < 0.05).
